Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,191 | 279 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,136 | 82 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $968.92 | 48 | $0 (2023) |
| Celgene Corporation | $416.18 | 43 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $407.07 | 23 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $333.62 | 36 | $0 (2024) |
| Ardelyx, Inc. | $193.67 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $167.52 | 10 | $0 (2024) |
| Gilead Sciences, Inc. | $133.89 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $104.81 | 6 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $71.33 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,287 | 93 | ABBVIE INC. ($495.70) |
| 2023 | $1,804 | 121 | NESTLE HEALTHCARE NUTRITION INC. ($543.62) |
| 2022 | $1,101 | 65 | Nestle HealthCare Nutrition Inc. ($425.30) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.47 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.79 | General |
| Category: GI | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Immunology | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.60 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: Gastroenterology | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: Gastroenterology | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Immunology | ||||||
| 10/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $2.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 347 | 485 | $61,857 | $21,976 |
| 2022 | 6 | 424 | 471 | $62,280 | $22,738 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 126 | 212 | $20,450 | $6,627 | 32.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 90 | 130 | $15,432 | $6,477 | 42.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 56 | 58 | $13,050 | $4,689 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 66 | $9,600 | $2,780 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 19 | $3,325 | $1,403 | 42.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 198 | 229 | $34,350 | $12,920 | 37.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 107 | 108 | $10,800 | $3,719 | 34.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 49 | $5,156 | $2,114 | 41.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $4,174 | $1,706 | 40.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 44 | 48 | $4,400 | $1,144 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $3,400 | $1,134 | 33.4% |
About Cristina Borsilli, NP
Cristina Borsilli, NP is a Family healthcare provider based in Munster, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2022. The National Provider Identifier (NPI) number assigned to this provider is 1629739131.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cristina Borsilli, NP has received a total of $4,191 in payments from pharmaceutical and medical device companies, with $1,287 received in 2024. These payments were reported across 279 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,191).
As a Medicare-enrolled provider, Borsilli has provided services to 771 Medicare beneficiaries, totaling 956 services with total Medicare billing of $44,714. Data is available for 2 years (2022–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Munster, IN
- Active Since 01/06/2022
- Last Updated 01/21/2026
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1629739131
Products in Payments
- ZENPEP (Drug) $857.08
- RINVOQ (Biological) $658.62
- ZEPOSIA (Drug) $389.22
- ENTYVIO (Biological) $384.91
- XIFAXAN (Drug) $293.94
- SKYRIZI (Biological) $196.42
- IBSRELA (Drug) $193.67
- VOWST (Biological) $162.98
- STELARA (Biological) $135.12
- CREON (Drug) $129.78
- DIFICID (Drug) $104.81
- LINZESS (Drug) $102.46
- Linzess (Drug) $71.33
- DUPIXENT (Biological) $70.54
- TRULANCE (Drug) $39.68
- VOQUEZNA (Drug) $35.90
- TREMFYA (Drug) $32.40
- HUMIRA (Biological) $25.79
- VIBERZI (Drug) $22.46
- EOHILIA (Drug) $22.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Munster
Mrs. Monika Vasic, Fnp, FNP
Family — Payments: $18,565
Sharon Henn, Np-C, NP-C
Family — Payments: $15,250
Donna Winterrowd
Family — Payments: $14,869
Mrs. Jacquelyn Adley, Np-C, NP-C
Family — Payments: $12,999
Lisa Poradzisz
Family — Payments: $10,254
Marissa Bottos, Fnp, Aprn, FNP, APRN
Family — Payments: $10,062